Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Managing bloating on GLP-1 treatments In most cases, bloating caused by GLP-1 can be effectively managed through a combination of dietary modifications, lifestyle changes, and appropriate medical support
Obesity-associated adipose tissue thus functions as an inflammatory endocrine organ, particularly in visceral tissue producing TNF-, IL-6, IL-1, Monocyte chemoattractant Protein 1 (MCP-1, which is associated with tamoxifen resistance), and leptin while reducing adiponectin (an anti-inflammatory adipokine) levels, thereby promoting chronic low-grade inflammation, insulin resistance, and tumor-promoting signaling pathways
Front Environ Sci 2:39
For patients seeking significant weight loss with obesity-related complications, retatrutide could become an important option - if the risk-benefit ratio aligns with their goals and they can tolerate the medication
US$ 29.18
US$ 23.93
US$ 22.08
